Jump to content
World's Largest Herpes Support Group
eitak90

Lasting symptoms

Recommended Posts

eitak90

I'm a few days diagnosed, and I believe my primary outbreak is over. 

However, I'm still without appetite and random pains on the lower half of my body. I want my appetite back! Does anyone else have this lasting symptom?

Share this post


Link to post
Share on other sites
Lisajd

This could possibly just be caused by the mental aspect you are having with it.  Are you feeling depressed at all or even other symptoms associated with the virus like when you get the flu you can lose your appetite

Share this post


Link to post
Share on other sites
eitak90

No I don't have any other symptoms except nerve pain and mild fatigue. I haven't had an appetite in weeks and I've lost about 9 lbs since I went to get swabbed for herpes. 

Maybe I'm scared to eat and upset the virus, but I know not eating doesn't help either. This whole situation is so much more complicated than I thought. I never knew how much this virus affects the body. 

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • The Hive is Thriving!

    • Total Topics
      70,111
    • Total Posts
      473,860
  • Posts

    • TCBH
      Another company looking to create a vaccine.  http://www.bluewillow.com/bluewillow-biologics-awarded-patent-for-intranasal-genital-herpes-vaccine/ BlueWillow’s intranasal NanoVax platform elicits both mucosal and systemic immunity through its novel oil-in-water nanoemulsion (NE) adjuvant, offering a unique advantage to combat sexually transmitted infections (STIs) including genital herpes. The mucosal immunity elicited by intranasal NE vaccines provides critical protection against infections at the port of entry by which a pathogen enters the body. The intranasal NanoVax HSV vaccine has demonstrated safety and efficacy in both prophylactic and therapeutic animal models for genital herpes. In a prophylactic guinea pig study, the intranasal vaccine prevented genital herpes infection in 92 percent of animals vaccinated. Therapeutic study animals previously infected with genital herpes who received the BlueWillow vaccine reduced recurrent lesions and viral shedding by more than 50 percent compared to animals who received no treatment.
    • JHenry
      Cas, This is sooooooo exciting I may need a diaper!  How bout you?  😊
    • JHenry
      This is wonderful news!  Impressive dollars raised and the team is absolutely outstanding.  For those who have been dreaming of the Bill and Melinda Gates Foundation on our side, consider your prayers answered.  William Jacobs and Betsy Herold from Einstein have “sounded” extremely confident all along.  While maybe not just “around the corner” this is amazingly exciting!   If there was ever a person that possibly could be a force in “fast tracking” could it be Mr. Bill Gates?  While it may seem “so far off”, for those of us having been infected for 20+ years or more, it is still music to our ears, and the  glass is always half full-without hope you have nothing.   Never forget this line from Shawshank Redemption:                                           “Hope is a good thing, maybe the best of things, and no good thing ever dies”. 
    • LightafterDarkness
      Discussion thread on this news here:  
    • LightafterDarkness
      This is pretty impressive for a number of reasons: Average funding for a series A in biotech is around ~$50M but the median is around ~$30M as of 2018 The takeaway then is the XVax is at the higher end of the spectrum suggesting (1) High investor interest, (2) XVax is thinking big A robust set of investors- good to see that there are multiple names here rather than 1-2. Again, suggests robust interest from investors Note that the anchor investor (i.e., the biggest) is Adjuvent who are backed by Bill and Melinda Gates Foundation, good to see that HSV continues to be of interest to them (my theory: due to the link with HIV and Alzheimer now)   Overall everyone should be cheering this news given the impressive results seen with animal models. Still remember this is going to be a multi year process- I would hope to see a phase I in 2020
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.